Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis
Deucravacitinib治疗炎症性肠病患者:3项随机II期研究(克罗恩病和溃疡性结肠炎)的12周疗效和安全性结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjaf080
D'Haens, Geert; Danese, Silvio; Panaccione, Remo; Rubin, David T; Peyrin-Biroulet, Laurent; Matsuoka, Katsuyoshi; Loftus, Edward V Jr; Kobayashi, Taku; Elsharkawi, Walid; Miceli, Rosa; Ahmed, Samia; Luo, Yi; Napoli, Andrew; Vaile, John; Dornic, Quentin; Patel, Aditya; Schreiber, Stefan